These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21418385)

  • 1. Epitope-dependent effects of Beta-amyloid antibodies on Beta-amyloid clearance in an in vitro model of the blood-brain barrier.
    Bachmeier CJ; Beaulieu-Abdelahad D; Mullan MJ; Paris D
    Microcirculation; 2011 Jul; 18(5):373-9. PubMed ID: 21418385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
    Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein.
    Candela P; Gosselet F; Saint-Pol J; Sevin E; Boucau MC; Boulanger E; Cecchelli R; Fenart L
    J Alzheimers Dis; 2010; 22(3):849-59. PubMed ID: 20858979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two β-strands of RAGE participate in the recognition and transport of amyloid-β peptide across the blood brain barrier.
    Kim SJ; Ahn JW; Kim H; Ha HJ; Lee SW; Kim HK; Lee S; Hong HS; Kim YH; Choi CY
    Biochem Biophys Res Commun; 2013 Sep; 439(2):252-7. PubMed ID: 23973487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Eur J Pharmacol; 2011 Jun; 659(2-3):124-9. PubMed ID: 21497592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
    Pflanzner T; Janko MC; André-Dohmen B; Reuss S; Weggen S; Roebroek AJ; Kuhlmann CR; Pietrzik CU
    Neurobiol Aging; 2011 Dec; 32(12):2323.e1-11. PubMed ID: 20630619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
    Deane R; Bell RD; Sagare A; Zlokovic BV
    CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro model.
    Poetsch V; Bennani-Baiti B; Neuhaus W; Muchitsch EM; Noe CR
    Pharmazie; 2010 Apr; 65(4):267-73. PubMed ID: 20432623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
    Zhu D; Su Y; Fu B; Xu H
    Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
    Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
    J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.
    Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH
    J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.
    Deane R; Du Yan S; Submamaryan RK; LaRue B; Jovanovic S; Hogg E; Welch D; Manness L; Lin C; Yu J; Zhu H; Ghiso J; Frangione B; Stern A; Schmidt AM; Armstrong DL; Arnold B; Liliensiek B; Nawroth P; Hofman F; Kindy M; Stern D; Zlokovic B
    Nat Med; 2003 Jul; 9(7):907-13. PubMed ID: 12808450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-derived immunoglobulins neutralize adverse effects of amyloid-beta peptide on the integrity of a blood-brain barrier in vitro model.
    Poetsch V; Neuhaus W; Noe CR
    J Alzheimers Dis; 2010; 21(1):303-14. PubMed ID: 20421696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood-brain barrier and Alzheimer's disease].
    Kuwahara H; Nishida Y; Yokota T
    Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.
    Mackic JB; Stins M; McComb JG; Calero M; Ghiso J; Kim KS; Yan SD; Stern D; Schmidt AM; Frangione B; Zlokovic BV
    J Clin Invest; 1998 Aug; 102(4):734-43. PubMed ID: 9710442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood-brain barrier.
    Rutgers KS; Nabuurs RJ; van den Berg SA; Schenk GJ; Rotman M; Verrips CT; van Duinen SG; Maat-Schieman ML; van Buchem MA; de Boer AG; van der Maarel SM
    Neuroscience; 2011 Sep; 190():37-42. PubMed ID: 21683126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.